Daniel D. Shoemaker
Overview
Daniel D. Shoemaker received an average of $1M in total compensation, including $344K in salary, at Fate Therapeutics from 2014 to 2020.
2020Fate TherapeuticsChief Scientific Officer
2019Fate TherapeuticsChief Scientific Officer
2018Fate TherapeuticsChief Scientific Officer
2017Fate TherapeuticsChief Scientific Officer
2016Fate TherapeuticsChief Scientific Officer
2015Fate TherapeuticsChief Scientific Officer
2014Fate TherapeuticsChief Scientific Officer
Source: SEC filings on April 21, 2021, March 22, 2019, March 16, 2018, March 22, 2017, and March 30, 2016.
Related executives
We found ten more executives who work or worked at Fate Therapeutics.
J Wolchko
Fate Therapeutics
Chief Executive Officer
Mark Plavsic
Fate Therapeutics
Chief Technology Officer
Bahram Valamehr
Fate Therapeutics
Chief Research and Development Officer
Cindy Tahl
Fate Therapeutics
General Counsel
Yu-Waye Chu
Fate Therapeutics
Chief Medical Officer
Edward Dulac
Fate Therapeutics
Chief Financial Officer
Christopher Storgard
Fate Therapeutics
Chief Medical Officer
Stewart Abbot
Fate Therapeutics